IYH iShares U.S. Healthcare ETF


$ 61.23 $ 0.01 (0.02 %)    

Thursday, 06-Nov-2025 11:12:25 EST
QQQ $ 613.41 $ -8.38 (-1.35 %)
DIA $ 469.07 $ -2.96 (-0.63 %)
SPY $ 671.10 $ -5.37 (-0.79 %)
TLT $ 89.69 $ 0.13 (0.15 %)
GLD $ 366.27 $ -0.88 (-0.24 %)
$ 61.33
$ 61.27
$ 61.21 x 720
$ 61.23 x 910
$ 61.09 - $ 61.40
$ 53.01 - $ 62.94
425,345
na
na
$ 0.65
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-is-co-diagnostics-stock-sinking-tuesday

Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns ab...

 wellgistics-and-datavault-team-up-to-transform-prescription-tracking

DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market.

 premier-set-for-private-ownership-eyes-growth-push

Premier Inc. to be acquired by Patient Square Capital at $28.25 per share, offering shareholders a 23.8% premium.

 brace-for-higher-healthcare-premiums-in-2026-as-insurers-blame-trumps-tariffs-in-filings-to-regulators-report

Health insurance companies have raised concerns that tariffs could lead to higher premiums for enrollees in the individual and ...

 guardian-pharmacy-strengthens-us-footprint-with-new-seattle-area-acquisition

Guardian Pharmacy Services acquires Mercury Pharmacy Services in Washington, expanding its presence in the Pacific Northwest a...

 tariffs-bite-dan-loebs-portfolio-thermo-fisher-hit-hard-discover-shines

Year to date, Thermo Fisher fell about 21.03%, both underperforming the iShares U.S. Healthcare ETF, which declined about 2.36%.

 dan-loeb-adjusts-healthcare-holdings-danaher-stake-trimmed-as-thermo-fisher-gains-favor

Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acqu...

 nih-funding-cuts-to-spook-healthcare-stocks-rfk-jrs-confirmation-at-hhs-sparks-concerns-over-research-dollars-causing-uncertainty-says-analyst

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

 spotify-vertiv-holdings-and-more-cnbcs-final-trades

Joseph M. Terranova picked Spotify Technology, which reported better-than-expected fiscal fourth-quarter 2024 financial sales.

 us-states-sue-national-institutes-of-health-over-4-billion-annual-cut-in-biomedical-research-grant-budget

A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set f...

 goldman-sachs-predicts-gradual-recovery-for-tools-and-contract-research-sector-in-2025-stable-large-pharma-spending-key-to-recovery

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved inv...

 world-health-organization-responds-to-trumps-order-reminds-decades-of-successful-health-achievements

Trump signs an order to withdraw the U.S. from WHO, citing pandemic mismanagement, political influence, and inequitable funding...

 stanley-druckenmillers-top-holding-has-outperformed-its-sector-by-252

Billionaire Stanley Druckenmiller's latest large wager on biotech company Natera Inc has paid off, with his stake now excee...

 your-healthcare-costs-are-soaring-us-spending-reached-5-trillion-in-2023-with-major-increase-in-obesity-and-diabetes-drugs-hospital-services

U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private i...

 fda-commissioner-califf-candid-on-trumps-impact-we-just-dont-know-whats-going-to-happen

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlight...

 deere-amgen-copart-and-more-cnbcs-final-trades

On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Deere & Company as his final t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION